Ignite Creation Date:
2024-05-05 @ 4:35 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00272701
Status:
COMPLETED
Last Update Posted:
2009-03-06
First Post:
2006-01-04
Brief Title:
Esomeprazole in PPI Failures - IMPROVE
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
A Randomised Open Phase IV Parallel Group Multicentre Study to Evaluate a Change of Management in Gastroesophageal Reflux Disease GERD Patients by Treatment With Esomeprazole 40 mg or Any Other Proton Pump Inhibitor PPI After Initial Treatment Failure in Ordinary Clinical Practice During 4 Weeks
Status:
COMPLETED
Status Verified Date:
2007-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess how PPI treated GERD patients with insufficient symptom control will benefit from a change in management by providing a more efficient acid secretion inhibition during 4 weeks by evaluation of esomeprazole 40 mg compared to pre-study PPI treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| EudraCT-number 2005-000458-57 | None | None | None |
| IMPROVE | None | None | None |